Medical News

RSS

New discovery in cancer and gene therapy

DNA's role as the master blueprint of the cell means that even small sequence changes can have catastrophic consequences. For this reason, much of our understanding of cancer development comes from studying how cells copy DNA and repair sequence errors--and how these processes can go wrong.

8 Apr 2011

NAFC honors UT Southwestern nurse with Continence Care Champion Award

The National Association For Continence presented Tamara Dickinson, RN, CURN, CCCN, BCB-PMD, with its Rodney Appell Continence Care Champion Award at the Society of Urologic Nurses and Associates luncheon on March 11, held during the 2011 SUNA Annual Symposium in New Orleans.

8 Apr 2011

Cosmic radiation can increase risk of atherosclerosis in astronauts

Astronauts anticipate more trips to the moon and manned missions to Mars. But exposure to cosmic radiation outside the Earth's magnetic field could be detrimental to their arteries, according to a study by University of Alabama at Birmingham researchers published April 6, 2011, online in the journal Radiation Research.

8 Apr 2011

Longer looks: Could Ryan's plan be a pitfall for Democrats?; the cost of military health care; revealing more about doctors' billing practices

Every week, reporter Jessica Marcy selects interesting reading from around the Web.

8 Apr 2011

Precision launches new tumor profiling product

Precision Therapeutics, Inc. announced that the launch of a new product line, BioSpeciFx, will help further the personalization of cancer treatments.

8 Apr 2011

Hope4Cancer offers gentle non-invasive therapies for patients with brain tumor

Linda Roberts was puzzled when her favorite food, chocolate ice cream, suddenly did not taste good, and her prized orchids didn't smell nice either. When she began having sudden, severe headaches, she mentioned the changes in taste and smell to her doctor. After several tests, Roberts was diagnosed with a glioblastoma multiforme, the most aggressive form of brain tumor.

8 Apr 2011

Idenix begins underwritten registered public offering of common stock

Idenix Pharmaceuticals, Inc., a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced that it has commenced an underwritten registered public offering of shares of its common stock. All of these shares are being sold by Idenix.

8 Apr 2011

New insight into acute pancreatitis

Timing is everything. That's especially true when it comes to the activation of enzymes created by the pancreas to break down food. When the timing is right, those enzymes are activated only when they reach the gut, where they get to work releasing and distributing nutrients that we need to survive.

8 Apr 2011

Virtual reality games can improve motor function in stroke patients

Virtual reality and other video games can significantly improve motor function in stroke patients, according to research from St. Michael's Hospital.

8 Apr 2011

ASBMB honors South Carolina researcher with Avanti Award for sphingolipid work

The American Society for Biochemistry and Molecular Biology has named Yusuf Hannun, professor and department chairman at the Medical University of South Carolina, in Charleston, S.C., the winner of the Avanti Award in Lipids.

8 Apr 2011

Michigan's CQI model improves patient outcomes, reduces health care costs

In a paper published today in the professional health care journal, Health Affairs, Blue Cross Blue Shield of Michigan and the University of Michigan Health System report that their model for collaborative health care quality improvement has measurably improved safety and quality in several clinical areas, and has saved millions in health care costs.

8 Apr 2011

AJG publishes new review on Inflammatory Bowel Disease management

The American College of Gastroenterology published a new evidence-based systematic review on the management of Inflammatory Bowel Disease as a supplement to The American Journal of Gastroenterology for April 2011, a special issue entirely dedicated to IBD.

8 Apr 2011

One-third of senior doctors are still working full time

More than 1 in 10 Canadian physicians is age 65 and older, but many doctors remain active in clinical practice after reaching the traditional retirement age, according to a study released today by the Canadian Institute for Health Information.

8 Apr 2011

Study: Hospital adverse-event figures exceed previous estimates

The research, which was published in the journal Health Affairs, used new tools to find that as many as one in three people in the U.S. will experience some type of mistake during a hospital stay. Also, the findings estimate the number of actual hospital errors to be as much as 10 times higher than found by voluntary reporting programs.

8 Apr 2011

New ATA recommendations on outpatient 131I therapy aim to treat thyroid cancer

New recommendations from the American Thyroid Association on outpatient radioiodine treatment aim to minimize unintended radiation exposure and maximize the safety of patients, their families, and the public.

8 Apr 2011

New study: Warning labels on junk food more effective than 'fat' tax

Warning labels on junk food would be more effective than a "fat" tax for deterring overweight people from making unhealthy purchases, a new University of Alberta study has found.

8 Apr 2011

BioParadox's VitaKine PCT can serve as promising therapy for heart attack patients

BioParadox, Inc., a regenerative medicine company pioneering point-of-care biologic treatments for cardiovascular disease, today announced data supporting the use of VitaKine- Platelet Cell Therapy as a promising treatment for heart attack patients.

8 Apr 2011

Study suggests depression treatment may have long-term benefits

Ian Colman, an epidemiologist in the School of Public Health at the University of Alberta, recently completed a study that suggests that treatment of depression may have long-term benefits.

8 Apr 2011

Johns Hopkins patient safety expert: Unreliable "outcomes" measures hamper efforts to assure better, safer care

With a push to make hospitals and doctors more accountable for health care quality, more attention must be paid to the accuracy and reliability of measures used to evaluate caregivers, says a prominent Johns Hopkins patient safety expert.

8 Apr 2011

Genzyme's alemtuzumab Phase 2 trial data in MS to be presented at AAN meeting

Genzyme, a subsidiary of sanofi-aventis Group, announced today that it will present new data from its completed Phase 2 trial of the investigational drug alemtuzumab for multiple sclerosis at the American Academy of Neurology's 63rd Annual Meeting in Hawaii, April 9 - 16, 2011.

8 Apr 2011